Tower Research Capital LLC (Trc) Reviva Pharmaceuticals Holdings, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.39 Billion
- Q3 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Reviva Pharmaceuticals Holdings, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 22,417 shares of RVPH stock, worth $11,208. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,417
Previous 1,424
1474.23%
Holding current value
$11,208
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding RVPH
# of Institutions
51Shares Held
9.75MCall Options Held
585KPut Options Held
31.6K-
Diadema Partners LP Morristown, NJ2.51MShares$1.25 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.92MShares$961,6140.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.71MShares$855,6100.0% of portfolio
-
Persistent Asset Partners LTD Hong Kong, K3594KShares$296,9510.15% of portfolio
-
Geode Capital Management, LLC Boston, MA559KShares$279,6210.0% of portfolio
About REVIVA PHARMACEUTICALS HOLDINGS, INC.
- Ticker RVPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,442,900
- Market Cap $10.2M
- Description
- Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...